Ivermectin for COVID-19: Concerns during pregnancy
Reprod Toxicol
.
2022 Jan:107:43.
doi: 10.1016/j.reprotox.2021.11.005.
Epub 2021 Nov 19.
Authors
L David Wise
1
,
Anthony R Scialli
2
Affiliations
1
Merck Research Laboratories (retired), 200 W. Washington Square, Philadelphia, PA, United States. Electronic address: l.david.wise@gmail.com.
2
Scialli Consulting LLC, 2737 Devonshire Pl NW #120, Washington DC, 20008-3459, United States. Electronic address: ascialli@scialliconsulting.com.
PMID:
34808313
PMCID:
PMC8603864
DOI:
10.1016/j.reprotox.2021.11.005
No abstract available
Publication types
Comment
MeSH terms
COVID-19*
Female
Humans
Ivermectin* / toxicity
Pregnancy
SARS-CoV-2
Substances
Ivermectin